Month: October 2013

WASHINGTON (Reuters) – Obamacare’s problem-plagued website Healthcare.gov will be fixed in time to allow people to enroll in private health insurance by a December 15 deadline to obtain benefits beginning on January 1, the main Obamacare contractor CGI Federal told a congressional panel. Executives representing CGI and another technology contractor, UnitedHealth Group unit Quality Software Services Inc. (QSSI), said they made no recommendation to U.S. officials on whether the site should open for enrollment on October 1. …

For Diabetics, Healthy Habits Trump Medicine

The weight loss food market is further segmented as meal replacements, low-calorie ready meals, sugar free confectionaries, low-calorie desserts, and organic …

By Ludwig Burger (Reuters) – McKesson agreed to buy German peer Celesio on Thursday for $8.3 billion, including debt, forging a global market leader in drugs distribution to boost its purchasing power with pharma majors. San Francisco-based McKesson, the largest U.S. drugs wholesale group, struck a deal to purchase the 50.01 percent stake in Celesio owned by the diversified holding company Franz Haniel & Cie and is offering to buy up the remaining shares for 23 euros ($31.7) apiece, it said on Thursday. McKesson and its closest U.S. …

(Reuters) – Rigel Pharmaceuticals Inc said it would stop the development of its drug to treat skin lesions in patients with discoid lupus, a chronic skin disease, after the treatment failed a mid-stage trial. Shares of the company fell nearly 9 percent to $3.24 in premarket trading. This is the third setback for Rigel this year and comes about two months after the company stopped the development of its asthma drug, which failed a mid-stage trial. British drugmaker AstraZeneca stopped developing Rigel’s rheumatoid arthritis treatment, fostamatinib, in June, which it licensed from Rigel in 2010. …